Vaughan Nelson Investment Management L.P. Purchases 66,219 Shares of Synopsys, Inc. $SNPS

Vaughan Nelson Investment Management L.P. raised its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 37.0% in the 1st quarter, Holdings Channel reports. The firm owned 245,217 shares of the semiconductor company’s stock after acquiring an additional 66,219 shares during the period. Synopsys accounts for approximately 1.0% of Vaughan Nelson Investment Management L.P.’s holdings, making the stock its 29th largest position. Vaughan Nelson Investment Management L.P.’s holdings in Synopsys were worth $97,224,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Victory Capital Management Inc. grew its position in Synopsys by 238.8% in the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after acquiring an additional 1,990,608 shares during the last quarter. Coatue Management LLC acquired a new stake in shares of Synopsys in the 3rd quarter valued at approximately $892,605,000. Capital Research Global Investors grew its holdings in shares of Synopsys by 226.6% during the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock valued at $1,245,533,000 after purchasing an additional 1,751,432 shares during the last quarter. Norges Bank bought a new stake in shares of Synopsys during the 4th quarter valued at approximately $730,197,000. Finally, State Street Corp increased its position in Synopsys by 20.6% during the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on SNPS. Wells Fargo & Company increased their price objective on shares of Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. Piper Sandler upped their price target on shares of Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a report on Thursday, May 28th. Morgan Stanley increased their price target on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research note on Thursday, May 28th. BNP Paribas Exane raised their price objective on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Finally, Needham & Company LLC restated a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Synopsys has an average rating of “Hold” and an average price target of $563.81.

Get Our Latest Research Report on SNPS

Insider Transactions at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $455.51 on Monday. The company has a market capitalization of $87.22 billion, a P/E ratio of 105.44, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The company’s 50 day moving average price is $479.14 and its 200-day moving average price is $462.21.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same period in the prior year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.